Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 111,900 shares, an increase of 27,875.0% from the December 31st total of 400 shares. Based on an average daily volume of 96,700 shares, […]
Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 111,900 shares, an increase of 27,875.0% from the December 31st total of 400 shares. Based on an average daily volume of 96,700 shares, […]
Oncotelic Therapeutics (OTCMKTS:OTLC – Get Free Report) and Bellicum Pharmaceuticals (NASDAQ:BLCM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Risk and Volatility Oncotelic Therapeutics has a […]
Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Rating) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 400 shares, a drop of 55.6% from the April 30th total of 900 shares. Based on an average daily trading volume, of 432,800 shares, the days-to-cover ratio is presently 0.0 […]
Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Rating) saw a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 400 shares, a decrease of 99.1% from the March 31st total of 42,900 shares. Based on an average daily volume of 187,700 shares, the short-interest ratio is […]